Augusta University

PRIM&R Announces New Executive Director

Retrieved on: 
Wednesday, September 20, 2023
HRPP, Doctor of Education, Mayo Clinic, Executive director, CIP, Augusta University, Education, PRIM, Lead, Public policy, Doctor of Philosophy, Science, CCRC, IRB, Sickle cell disease, Ethics, R, Clinical professor, AROS Research Operating System, DVM, PRIM&R, Management, Research, Medicine

“After an extensive search and careful consideration, I am thrilled to announce that Ivy Tillman has accepted the position of Executive Director.

Key Points: 
  • “After an extensive search and careful consideration, I am thrilled to announce that Ivy Tillman has accepted the position of Executive Director.
  • “I am honored to take on the role of Executive Director and work with PRIM&R’s dedicated staff.
  • Elisa A. Hurley, PhD, the second Executive Director since PRIM&R’s founding in 1974, stepped down on August 18 after leading the nonprofit for nine years.
  • Dr. Hurley described her tenure leading PRIM&R as “wonderful, challenging, fulfilling.”
    Dr. Tillman will officially begin her role as PRIM&R’s Executive Director on October 16.

Eric Kmiec, Ph.D., Named Editor-in-Chief of Gene and Genome Editing

Retrieved on: 
Wednesday, September 6, 2023
Kmiec, DNA, CRISPR, Gene, Augusta University, Genetics, Stanford University, Medical college, Gene editing, Pathology, Cancer, Medical College of Georgia, Inherited disorders of trafficking, Research, Lung, Master of Science, Knowledge, FDA, Therapy, Molecular medicine, Environment, Homologous recombination, Antibiotics, Vaccine

Wilmington, Delaware, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Eric Kmiec, Ph.D., executive director and chief scientific officer of ChristianaCare’s Gene Editing Institute , has been selected as editor-in-chief of the scientific journal Gene and Genome Editing .

Key Points: 
  • Wilmington, Delaware, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Eric Kmiec, Ph.D., executive director and chief scientific officer of ChristianaCare’s Gene Editing Institute , has been selected as editor-in-chief of the scientific journal Gene and Genome Editing .
  • “We have a unique opportunity to fill a void in the field by focusing on clear messages about the foundational aspects of gene editing and accepting papers that cover groundbreaking gene editing discoveries.”
    “I am delighted with Eric’s appointment and the plans he has to take the journal in a new direction,” said Susanne Steiginga, MSc, executive publisher of Gene and Genome Editing.
  • He is widely recognized for his pioneering work in the fields of molecular medicine and gene editing.
  • Throughout his professional career, Kmiec has led research teams in developing gene editing technologies and genetic therapies for inherited disorders and cancer.

Bionano Announces Presentation of Optical Genome Mapping (OGM) Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting

Retrieved on: 
Friday, August 11, 2023
Diamond, CGC, Court of general sessions, University, Augusta University, Workflow, Genomics, NGS, University of Washington, Cancer, Bone marrow, Research, Oxford University Hospitals NHS Foundation Trust, International Cancer Genome Consortium, MD Anderson Cancer Center, Chemistry, SAN, Annual general meeting, California Hospital Medical Center, Children's Hospital Los Angeles, Hospital, Cytogenetics, Leukemia, Panel discussion, Nationwide, OGM, Very important person, Medical device, Vaccine, Medical imaging

CGC’s annual meeting brings together industry, medical, and academic professionals to discuss advances in clinical genomics for oncology research.

Key Points: 
  • CGC’s annual meeting brings together industry, medical, and academic professionals to discuss advances in clinical genomics for oncology research.
  • During this interactive session, experts will discuss their experience implementing OGM, key applications, and potential implications for future clinical research and medical guidelines.
  • Thirteen separate scientific presentations highlighting OGM as a novel technique in cancer research will be given at the conference.
  • In addition, three posters featuring results from OGM applications in cytogenetics and cancer research will be presented at the conference.

Peach State Health Plan and the Medical College of Georgia at Augusta University Announce 2023 Peach State Scholars

Retrieved on: 
Monday, August 7, 2023
Partnership, Emergency medicine, Augusta University, Centene Corporation, Medical college, Ageing, Medical College of Georgia, GA, Doctor of Philosophy, Student, Retirement, Physician, Internal medicine, Psychiatry, 157th Georgia General Assembly, Nursing

ATLANTA, Aug. 7, 2023 /PRNewswire/ -- Last week, leaders from Peach State Health Plan, a care management organization that serves the needs of Georgians through a range of health insurance solutions and wholly owned subsidiary of Centene Corporation, and the Medical College of Georgia at Augusta University, announced the 2023 "Peach State Scholars." The nine medical students were announced during an official pinning ceremony held at Augusta University. The students are the third class of Peach State Scholars participating in the Medical College of Georgia's 3+ Primary Care Pathway Program, a program established in 2021 that focuses on alleviating Georgia's physician shortage.

Key Points: 
  • The students are the third class of Peach State Scholars participating in the Medical College of Georgia's 3+ Primary Care Pathway Program, a program established in 2021 that focuses on alleviating Georgia's physician shortage.
  • "Our partnership with Peach State Health Plan has been critical to getting the MCG3+ Primary Care Pathway Program off the ground to address Georgia's doctor shortages," said Augusta University President Brooks A.
  • "We have been proud to support the MCG3+ Primary Care Pathway program since its inception and are excited to see it expand into its third year with the 2023 Peach State Scholars," said Peach State Health Plan CEO, Wade Rakes.
  • The 2023 Peach State Scholars, their hometowns and intended specialty are as follows:
    Christopher "Chris" Dick of Dunwoody, GA, Internal Medicine
    Brianna "Taylor" Nicholson of Suwanee, GA, Psychiatry

Hampton Groover, MD, Named Chief Medical Officer at Haven

Retrieved on: 
Thursday, July 13, 2023
Atlanta Medical Center, Central Florida, Bachelor of Science, University, Augusta University, Internal medicine, Medical college, Medical College of Georgia, Nursing, Medical director, MD, Palliative care, Hospice, Biology, RN, MHA, Health system, Science

GAINESVILLE, Fla., July 13, 2023 /PRNewswire/ -- Hampton Groover, MD, has been named Chief Medical Officer of Haven, North Central Florida's legacy mission-driven provider of hospice and palliative care. With a career that includes working in hospice and palliative care—as well as extensive academic experience—Dr. Groover brings years of relevant experience to Haven.

Key Points: 
  • GAINESVILLE, Fla., July 13, 2023 /PRNewswire/ -- Hampton Groover, MD, has been named Chief Medical Officer of Haven, North Central Florida's legacy mission-driven provider of hospice and palliative care.
  • As Chief Medical Officer, Dr. Groover serves as a member of senior leadership and oversees Haven's team of skilled providers across its 18-county service area.
  • "It is a privilege to welcome such an esteemed professional as our new Chief Medical Officer," noted Haven President and Chief Operating Officer Pauline Taylor, RN, MHA.
  • Dr. Groover came to Haven from St. Mary's Health Care System, Athens, Ga., where he served as Medical Director of its inpatient palliative medicine program.

Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and a 523-gene NGS Panel for Standard Evaluation of Myeloid Cancers

Retrieved on: 
Tuesday, June 20, 2023
Medicine, FISH, Augusta University, National Health Service, Workflow, Genomics, KT, NGS, National Comprehensive Cancer Network, Karyotype, NCCN, MDS, Patient, SAN, NHS, OGM, Gene, VIA, Software, Medical imaging, Cancer

SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), today announced the publication in Cancers of a peer-reviewed study from Augusta University on the utility of combining optical genome mapping (OGM) and a 523-gene next-generation sequencing (NGS) panel for the standard evaluation of myeloid cancers.

Key Points: 
  • SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), today announced the publication in Cancers of a peer-reviewed study from Augusta University on the utility of combining optical genome mapping (OGM) and a 523-gene next-generation sequencing (NGS) panel for the standard evaluation of myeloid cancers.
  • The study describes myeloid cancers as posing a significant challenge to manage, with approximately 50% of cases displaying cytogenetically normal genomes, which can confound traditional analysis approaches.
  • In this blinded retrospective analysis of samples from 30 myeloid cancer subjects, the combination of OGM with the 523-gene NGS panel was compared to the common approach of KT and FISH combined with a 54-gene NGS panel.
  • A pre-commercial version of Bionano’s new NxClinical™ software enabled analysis of OGM and NGS data together, providing an integrated picture of genomic variation.

ReFrame Solutions Appoints P. Kelly Farr Jr. as Chief Strategy Officer to Drive Innovation and Growth

Retrieved on: 
Wednesday, June 7, 2023
Public sector, Lucent, Growth, SAS Institute, ReFrame, Ministry of Finance, Economic Stabilization and National Policies, Augusta University, Strategic planning, Pakistan Software Export Board, CSO, Management

In this role, Kelly will be responsible for developing and executing strategic initiatives that drive innovation, growth, and customer excellence across the organization.

Key Points: 
  • In this role, Kelly will be responsible for developing and executing strategic initiatives that drive innovation, growth, and customer excellence across the organization.
  • "We are thrilled to welcome Kelly to the executive team as our new Chief Strategy Officer," said Scott Schooley, Chairman of the Board.
  • "I am honored to join ReFrame Solutions as Chief Strategy Officer," said Kelly Farr "I believe that ReFrame has tremendous potential for further growth and innovation, and I am excited to work alongside a talented team to shape the company's strategic direction.
  • His proven ability to drive strategic vision, combined with his passion for innovation, makes him an invaluable addition to the ReFrame Solutions leadership team.

Dr. Peter Staats, Chief Medical Officer at National Spine and Pain, Joins the Neuralace Medical Advisory Board as the Company Continues its Successful Seed Round Fundraising, Building Off the First Close of $3.1M While Targeting a Total Capital Raise of $

Retrieved on: 
Thursday, May 25, 2023
Augusta University, Medical college, Department of Defence, Medical College of Georgia, DRS, Axon, Veterans Health Administration, Veteran, Associate, PNS, Charlie Norwood, Pain, Addiction medicine, Society of Chest Pain Centers, Patient, Pain Clinic, Pain management, FDA, Dentistry, Medical device, Bedder

SAN DIEGO, May 25, 2023 /PRNewswire/ -- Neuralace Medical, Inc., a leading medical technology company specializing in innovative non-invasive solutions for the treatment of chronic peripheral neuropathic pain, is pleased to welcome Dr. Peter Staats, Chief Medical Officer at National Spine and Pain Centers, based in Frederick, MD., to the Neuralace Medical Advisory Board. Dr. Staats brings extensive expertise to the company and will collaborate with the advisory board and Neuralace Medical to contribute valuable insights and strategic guidance. He expressed his enthusiasm for Axon Therapy, stating, "I have seen Axon Therapy progress from an interesting project several years ago, to what is now an FDA cleared, clinically impactful treatment. Axon Therapy is an excellent complement to conventional, implantable neuromodulation, bringing the benefits of neurostimulation to many more patients. I look forward to working alongside Drs. Sayed (KU Medical Center), Kapural (Carolina Pain Institute), and Bedder (VAMC Augusta) to support the market entry of this much-needed non-invasive approach."

Key Points: 
  • Dr. Staats brings extensive expertise to the company and will collaborate with the advisory board and Neuralace Medical to contribute valuable insights and strategic guidance.
  • Axon Therapy is an excellent complement to conventional, implantable neuromodulation, bringing the benefits of neurostimulation to many more patients.
  • Sayed (KU Medical Center), Kapural (Carolina Pain Institute), and Bedder (VAMC Augusta) to support the market entry of this much-needed non-invasive approach."
  • This milestone establishes Charlie Norwood VA Medical Center as the first VA Medical Center to incorporate Axon Therapy into its treatment regimen.

Marietta Dental Professionals, Announces that Three New Dentists Have Joined the Practice, Dr. Ray Cornay, Dr. Melissa Wendling and Dr. Vishal Patel

Retrieved on: 
Friday, May 19, 2023
American Dental Association, Dentistry, Augusta University, Education, DDM, Dental implant, Tufts University School of Dental Medicine, Roseman University of Health Sciences, Science, Dentist, Orthodontics, Patient, Outline of health sciences, Endodontics, Dental care, Nothing to fear but fear itself, Knowledge, Roswell

MARIETTA, Ga., May 19, 2023 /PRNewswire-PRWeb/ -- At Marietta Dental Professionals, they are dedicated to creating dream smiles in a responsible and conservative way. Patients can receive the dental care they need and deserve, ranging from preventative dental cleanings, Orthofx (clear aligners) to full-service dental implants.

Key Points: 
  • MARIETTA, Ga., May 19, 2023 /PRNewswire-PRWeb/ -- At Marietta Dental Professionals , they are dedicated to creating dream smiles in a responsible and conservative way.
  • Patients can receive the dental care they need and deserve, ranging from preventative dental cleanings , Orthofx (clear aligners) to full-service dental implants.
  • Dr. Dipesh Patel and the team at Marietta Dental Professionals are thrilled to have these three elite dental professionals join the staff.
  • For more information about the services offered at Marietta Dental Professionals, please visit http://www.mariettadentalpros.com or call (770) 514-5055.

Bionano Reports First Quarter 2023 Results and Highlights Recent Business Progress

Retrieved on: 
Tuesday, May 9, 2023
HRD, Genomics, GAAP, Curie Institute (Paris), Doctor of Philosophy, Acquisition, Investment, Risk, DSM-IV codes, Bone marrow, University, NGS, Spectrum, Mosaic, Research, Whole genome sequencing, LRS, Children's Hospital Los Angeles, WGS, Growth, Hospital, OEM, OGM, NMPA, Trisomy, Total, BGPT, MRKH, DNA, Workflow, Cancer, SOC, Publication, Genetic disorder, Standard of care, University of Toronto, ASD, SAN, National Medical Products Administration, IVD, MD Anderson Cancer Center, Acceleration, Toronto, SVS, Sale, NVIDIA, Female, Breast cancer, Mobile phone, Video game, Medical device, Pharmaceutical industry, Dietary supplement, Renewable energy, Augusta University

GAAP gross margin for the first quarter of 2023 was 28%, compared to 15% from the first quarter of 2022.

Key Points: 
  • GAAP gross margin for the first quarter of 2023 was 28%, compared to 15% from the first quarter of 2022.
  • First quarter 2023 non-GAAP¹ gross margin was 30%, compared to 15% from the first quarter of 2022.
  • First quarter 2023 GAAP operating expense was $39.9 million, compared to $30.8 million in the first quarter of 2022.
  • First quarter 2023 non-GAAP operating expense was $33.6 million, compared to $24.2 million in the first quarter of 2022.